Centre for Pain Research, University of Bath, Bath, United Kingdom.
Cochrane Pain, Palliative and Supportive Care Review Group, Oxford, United Kingdom.
Pain. 2022 Jan 1;163(1):e1-e19. doi: 10.1097/j.pain.0000000000002297.
Chronic pain in childhood is an international public health problem. We conducted a systematic review and meta-analysis to provide a summary of the published evidence of pharmacological, physical, and psychological therapies for children with chronic pain conditions. We searched CENTRAL, MEDLINE, EMBASE, and PsycINFO from inception to April 2020; clinical trial registries; and other sources for randomised controlled trials or comparative observational trials. We extracted critical outcomes of pain intensity, quality of life, physical functioning, role functioning, emotional functioning, sleep, and adverse events. We assessed studies for risk of bias and certainty of the evidence using GRADE. We included 34 pharmacological (4091 participants), 25 physical therapy (1470 participants), and 63 psychological trials (5025 participants). Participants reported a range of chronic pain conditions. Most studies were assessed to have unclear or high risk of bias across multiple domains. Pharmacological, physical, and psychological therapies showed some benefit for reducing pain, posttreatment, but only physical and psychological therapies improved physical functioning. We found no benefit of any treatment modality for health-related quality of life, role functioning, emotional functioning, or sleep. Adverse events were poorly reported, particularly for psychological and physical interventions. The largest evidence base for the management of chronic pain in children supports the use of psychological therapies, followed by pharmacological and physical therapies. However, we rated most outcomes as low or very low certainty, meaning further evidence is likely to change our confidence in the estimates of effects. This protocol was registered on PROSPERO (CRD42020172451).
儿童慢性疼痛是一个国际性的公共卫生问题。我们进行了系统评价和荟萃分析,以总结已发表的针对慢性疼痛儿童的药理学、物理和心理治疗的证据。我们从建库起至 2020 年 4 月在 CENTRAL、MEDLINE、EMBASE 和 PsycINFO 中检索、临床试验注册库以及其他来源检索随机对照试验或比较观察性试验。我们提取了疼痛强度、生活质量、身体功能、角色功能、情绪功能、睡眠和不良事件等关键结局的资料。我们使用 GRADE 评估了研究的偏倚风险和证据确定性。我们纳入了 34 项药理学(4091 名参与者)、25 项物理治疗(1470 名参与者)和 63 项心理治疗试验(5025 名参与者)。参与者报告了一系列慢性疼痛状况。大多数研究在多个领域被评估为存在不明确或高偏倚风险。药理学、物理和心理治疗在治疗后显示出减轻疼痛的一定益处,但只有物理和心理治疗改善了身体功能。我们没有发现任何治疗方式对健康相关生活质量、角色功能、情绪功能或睡眠有改善作用。不良事件报告得很差,尤其是对心理和物理干预。支持儿童慢性疼痛管理的最大证据基础是使用心理治疗,其次是药理学和物理治疗。然而,我们将大多数结局的确定性评为低或极低,这意味着进一步的证据可能会改变我们对疗效评估的信心。本方案已在 PROSPERO(CRD42020172451)上注册。